Centerline Biomedical Raises $33 Million In Series B Financing
06/27/22, 8:00 AM
Location
clevelandMoney raised
$33 million
Round Type
series b
Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series B equity financing led by Cleveland Clinic with participation by GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures. This funding will help propel the company into new surgical applications, accelerate its commercial sales and add to its growing clinical evidence repository.
Company Info
Location
cleveland, ohio, united states
Additional Info
Centerline Biomedical, Inc. was founded in 2014 as a spinoff of the Cleveland Clinic to commercialize our innovative vascular navigation technology. With a research, development, and design history rooted in the Clinic’s world-class Lerner Research Institute’s Heart and Vascular Institute, the IOPS™ platform can be further used for predictive modeling, clinical decision support, global healthcare analytics and the education and training of future surgeons and interventionists.